Inactive Instrument
Bellicum Pharmaceuticals, Inc. Share Price OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 17.65L 15.54L 14.72L 13.29L 25.05L 17Cr 25.38L 1.76Cr 67.8L 8.65Cr 66.27L 64.82L 28Cr | P/E 2021 |
-1.77x | P/E 2022 | -0.89x |
|---|---|---|---|---|---|
| Enterprise Value | -2.01Cr -1.77Cr -1.67Cr -1.51Cr -2.85Cr -192.46Cr -2.89Cr -20Cr -7.71Cr -98Cr -7.54Cr -7.37Cr -315.44Cr | EV / Sales 2021 |
-5.43x | EV / Sales 2022 | -10.4x |
| Free-Float |
98.45% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 23/02/2024 |
Richard Fair
CEO | Chief Executive Officer | 57 | 31/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 8L | |
| +4.16% | -0.30% | +58.96% | +94.17% | 7.15TCr | |
| -0.19% | -1.01% | +38.55% | +83.85% | 6.01TCr | |
| -1.51% | +2.20% | +10.66% | +35.15% | 4.89TCr | |
| -0.05% | -0.46% | +48.77% | +36.65% | 4.43TCr | |
| +0.38% | +6.43% | +345.54% | +641.55% | 4.38TCr | |
| +0.18% | -0.58% | +9.95% | +103.45% | 4.15TCr | |
| -0.67% | -0.45% | +4.47% | +46.37% | 3.01TCr | |
| +4.77% | +6.46% | +41.54% | +22.78% | 2.8TCr | |
| -1.29% | -5.53% | -19.42% | +352.04% | 2.53TCr | |
| Average | -0.05% | +0.48% | +59.89% | +157.33% | 4.37TCr | |
| Weighted average by Cap. | +0.85% | +0.63% | +65.00% | +148.55% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 62L 54.6L 51.73L 46.7L 88.02L 59Cr 89.16L 6.19Cr 2.38Cr 30Cr 2.33Cr 2.28Cr 97Cr | 15L 13.21L 12.52L 11.3L 21.29L 14Cr 21.57L 1.5Cr 57.62L 7.35Cr 56.32L 55.1L 24Cr |
| Net income | -97.05L -85.46L -80.97L -73.1L -1.38Cr -93Cr -1.4Cr -9.69Cr -3.73Cr -48Cr -3.64Cr -3.56Cr -152.52Cr | -2.5Cr -2.2Cr -2.08Cr -1.88Cr -3.55Cr -239.45Cr -3.59Cr -25Cr -9.59Cr -122.41Cr -9.38Cr -9.17Cr -392.45Cr |
| Net Debt | -4.62Cr -4.06Cr -3.85Cr -3.48Cr -6.55Cr -442.56Cr -6.64Cr -46Cr -18Cr -226.24Cr -17Cr -17Cr -725.35Cr | -2.18Cr -1.92Cr -1.82Cr -1.64Cr -3.1Cr -209.38Cr -3.14Cr -22Cr -8.39Cr -107.04Cr -8.2Cr -8.02Cr -343.17Cr |
Employees
13
